false
ar,be,bn,zh-CN,zh-TW,en,fr,de,hi,it,ja,ko,pt,ru,es,sw,vi
Catalog
Novel combinations for treatment of recurrent cerv ...
Recording
Recording
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
This video is a discussion between Dr. Brad Monk, Director of the GOG Foundation, and Dr. Wendell Mellon, Associate Director of Clinical Trials at Levine Cancer Institute. The focus of the discussion is on the advancements in the treatment of recurrent metastatic cervical cancer. Dr. Monk discusses various treatment options, including combination therapies and targeted therapies. He highlights the positive outcomes of recent clinical trials and emphasizes the importance of early detection and prevention through vaccination and screening. Dr. Mellon raises questions about the sequencing of treatments and the potential impact of radiation therapy on immune response. Dr. Monk also mentions ongoing and upcoming trials, including those investigating tissue factor ADCs and combinations with checkpoint inhibitors. He concludes by mentioning the upcoming IGCS meeting in Seoul and encourages viewers to attend. The transcript does not explicitly mention any credits granted.
Keywords
recurrent metastatic cervical cancer
treatment options
clinical trials
early detection
radiation therapy
immune response
IGCS meeting
Contact
education@igcs.org
for assistance.
×